Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Arylacetamide Deacetylase-Like 1 Antibody is a Rabbit Polyclonal antibody against Arylacetamide Deacetylase-Like 1.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | Arylacetamide Deacetylase-Like 1 (AADACL1) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Antigen Affinity Chromatography. |
Size 1 | 100 µl |
Form | Liquid |
Tested Applications | ELISA, WB |
Buffer | PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q6PIU2 |
Gene ID | 57552 |
NCBI Accession | NP_001139748.1 |
OMIM | 613234 |
Alias | NCEH1,AADACL1,NCEH, Arylacetamide deacetylase like 1 |
Background | Antibody anti-NCEH1 |
Status | RUO |
Descripción
Neutral cholesterol ester hydrolase 1 (NCEH1) is an enzyme involved in the hydrolysis of cholesterol esters into free cholesterol and fatty acids, playing a critical role in cholesterol metabolism and homeostasis. It is primarily localized in the cytosol and is highly expressed in tissues such as the liver, macrophages, and adrenal glands, where cholesterol metabolism is vital. NCEH1 contributes to the regulation of intracellular cholesterol levels and is involved in processes such as lipid droplet mobilization and reverse cholesterol transport. It also plays a significant role in foam cell formation in atherosclerotic plaques, highlighting its involvement in cardiovascular disease. Dysregulation or mutations in NCEH1 have been linked to lipid metabolism disorders and increased susceptibility to atherosclerosis, making it a potential therapeutic target for modulating cholesterol homeostasis and reducing cardiovascular risk.
Related Products

anti- AADACL1 antibody
AADACL1(Arylacetamide deacetylase-like 1) is also named as NCEH1, KIAA1363 and belongs to the 'GDXG' lipolytic enzyme family. The transmembrane enzyme, AADACL1, controls the production of the monoalkylglycerol ether(MAGE) class of NELs in cancer cells and acts as a 2-acetyl MAGE hydrolase and is likely the principal source for this activity in tumor cells(PMID:21513884). The full length protein has three glycosylation sites and can be N-glycosylated(PMID:19159218). It has 3 isoforms produced by alternative splicing.
Ver Producto
Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody
Arylacetamide Deacetylase-Like 1 Antibody is a Rabbit Polyclonal antibody against Arylacetamide Deacetylase-Like 1.
Ver Producto
Neutral cholesterol ester hydrolase 1 (NCEH1) Antibody
NCEH1 Antibody is a Rabbit Polyclonal against NCEH1.
Ver Producto